# Vascular Medcure, Inc.

- Location (FDA's records): Anaheim, CA
- FDA decisions: 5 (2019–2020): 5 510(k) clearances
- Product codes: QEW (5)
- 510(k) review time since 2016: median 29 days, against 105 for FDA's reviews in the same codes and years (4 of 5 faster)
- Predicates its devices cite: 5 (3 its own); citations of its devices by later devices: 3 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Kp Medcure, Inc.: 2 (https://510kreport.com/company/kp-medcure)

## Its most-cited devices
- K200314: Capere Thrombectomy System (2020), cited by 1
- K192935: CAPERE Thrombectomy System (2019), cited by 1
- K183179: CAPERE Thrombectomy System (2019), cited by 1

## Recent decisions
- K203476: CAPERE Thrombectomy System (Dec 22, 2020)
- K201216: CAPERE Thrombectomy System (Jul 8, 2020)
- K200314: Capere Thrombectomy System (Mar 4, 2020)
- K192935: CAPERE Thrombectomy System (Nov 15, 2019)
- K183179: CAPERE Thrombectomy System (Feb 25, 2019)

Source page: https://510kreport.com/company/vascular-medcure